
STRAW+10: The Stages of Reproductive Ageing
STRAW+10 — the Stages of Reproductive Aging Workshop criteria, updated in 2011 — is the standard framework clinicians and researchers use to describe where a woman is in the reproductive ageing process. It divides life from the reproductive years through postmenopause into stages, defined mainly by menstrual-cycle regularity and, where relevant, hormone markers. This guide explains the stages in plain terms. Educational information only, not medical advice.
The core idea: reproductive ageing is a continuous process, and its clearest outward sign is the menstrual cycle. STRAW+10 names the stages so symptoms and findings can be discussed precisely.
The stages
STRAW+10 numbers stages from negative to positive, with zero at the final menstrual period (FMP):
Reproductive years (negative stages)
- Stage -5 (early reproductive): regular cycles; peak fertility in the earlier years.
- Stage -4: regular cycles, with fertility beginning to decline through the later reproductive years.
- Stage -3 (late reproductive): cycles remain regular, but hormone markers begin to shift — notably a falling anti-Müllerian hormone (AMH) and, in some women, a rising follicle-stimulating hormone (FSH) in the early follicular phase. Fertility is reduced.
Menopausal transition (negative stages)
- Stage -2 (early transition): cycle length varies by seven days or more from the woman's norm; FSH is typically elevated. Symptoms such as hot flushes can begin.
- Stage -1 (late transition): the hallmark is skipped cycles — an interval of 60 days or more between periods — with more pronounced symptoms and higher FSH.
Postmenopause (positive stages)
- Stage 0: the final menstrual period (FMP), identified in hindsight after twelve months without bleeding.
- Stage +1 (early postmenopause): the first years after the FMP; vasomotor symptoms are often most intense, and bone loss accelerates.
- Stage +2 (late postmenopause): further years on; symptoms such as vaginal dryness and bladder changes typically persist or worsen, while hot flushes may settle in some women.
What defines each stage
| Marker | What it shows |
| Menstrual cycle | The primary outward marker — regularity, then variability, then skipped cycles, then absence. |
| FSH | Rises as ovarian reserve falls; used to support staging, though it fluctuates in the transition. |
| AMH | Falls steadily across the reproductive years; a marker of ovarian reserve. |
| Antral follicle count | Declines with ovarian reserve, assessed on ultrasound where indicated. |
How it helps in practice
- It explains the timing of symptoms. Hot flushes typically begin in the transition and peak around early postmenopause; urogenital symptoms come later and persist.
- It frames fertility. Fertility declines through the late reproductive years and is markedly reduced by the late transition.
- It guides bone health. Bone loss accelerates around the FMP, so the early postmenopausal years are when protection matters most.
- It gives a shared language for conversations with clinicians.
Educational information only — not medical advice. Staging is a descriptive framework; symptoms and treatment decisions are individual. Consult a qualified clinician.
← All guides